Hugh Johnson Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-21,840
Closed -$1.95M 96
2018
Q3
$1.95M Buy
21,840
+90
+0.4% +$7.95K 0.54% 47
2018
Q2
$1.73M Buy
21,750
+385
+2% +$32K 0.5% 48
2018
Q1
$1.91M Sell
21,365
-135
-0.6% -$13K 0.57% 49
2017
Q4
$2.24M Buy
21,500
+4
+0% +$451 0.66% 45
2017
Q3
$3.13M Buy
21,496
+45
+0.2% +$6.13K 0.94% 38
2017
Q2
$2.79M Sell
21,451
-370
-2% -$45.3K 0.89% 39
2017
Q1
$2.71M Sell
21,821
-510
-2% -$61K 0.89% 40
2016
Q4
$2.58M Buy
22,331
+325
+1% +$36.2K 0.89% 41
2016
Q3
$2.3M Sell
22,006
-535
-2% -$57.9K 0.85% 44
2016
Q2
$2.22M Buy
22,541
+215
+1% +$22.2K 0.86% 43
2016
Q1
$2.23M Buy
22,326
+90
+0.4% +$9.27K 0.88% 42
2015
Q4
$2.66M Sell
22,236
-50
-0.2% -$5.79K 1.02% 38
2015
Q3
$2.41M Sell
22,286
-150
-0.7% -$18.6K 0.98% 43
2015
Q2
$2.6M Sell
22,436
-70
-0.3% -$8K 0.92% 43
2015
Q1
$2.59M Sell
22,506
-240
-1% -$28.7K 0.87% 47
2014
Q4
$2.54M Buy
+22,746
New +$2.4M 0.89% 49

Other funds holding CELG

Hugh Johnson Advisors's CELG Position: Q4 2018 in Review

Hugh Johnson Advisors sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 21,840 shares — an estimated $1.95M sold.

Hugh Johnson Advisors first reported a position in CELG in Q4 2014 and held it in 16 quarters. The position peaked at $3.13M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Hugh Johnson Advisors reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Hugh Johnson Advisors sold 21,840 Celgene Corp shares in Q4 2018, an estimated $1.95M.
  • Hugh Johnson Advisors first reported a position in Celgene Corp in Q4 2014 and held it in 16 quarters.
  • Hugh Johnson Advisors's Celgene Corp position peaked at $3.13M in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Hugh Johnson Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.